Basic Information
| LncRNA/CircRNA Name | RP11-396F22.1 |
| Synonyms | NA |
| Region | GRCh38_12:38906451-38909592 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | Microarray, qPCR, in vitro knockdown etc. |
| Sample | cell lines (SiHa, HeLa, C33a and Ms751) |
| Expression Pattern | up-regulated |
| Function Description | RP11-396F22.1 might regulate Cpne8 expression via miRNA-32.Indeed, we found that knock down of RP11-396F22.1 significantly down regulated miRNA-32 expression |
| Pubmed ID | 29636859 |
| Year | 2018 |
| Title | Overexpression of long non-coding RNA RP11-396F22.1 correlates poor prognosis of patients with early-stage cervical cancer. |
External Links
| Links for RP11-396F22.1 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |